Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
Go back to Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market| GALMED PHARMACEUTIC (NASDAQ: GLMD) | Delayed: 0.57 +0.01 (1.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.56 | 52 Week High | $9.70 | |||
| Open | $0.53 | 52 Week Low | $2.78 | |||
| Day High | $0.57 | P/E | N/A | |||
| Day Low | $0.53 | EPS | $0.00 | |||
| Volume | 36,069 | |||||
